» Articles » PMID: 34063672

US Nicotine Vaping Product Simulation Model: The Effect of Vaping and Tobacco Control Policies on Smoking Prevalence and Smoking-Attributable Deaths

Overview
Publisher MDPI
Date 2021 Jun 2
PMID 34063672
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The public health impact of nicotine vaping products (NVPs) is subject to a complex set of uncertain transitions between NVP and cigarette use. Instead, we apply an indirect method to gauge the impact of NVP use on smoking prevalence and smoking-attributable deaths (SADs) using the well-established tobacco control policy simulation model. Upon validating the model before NVPs were more widely used, we project a No-NVP (i.e., in the absence of NVPs) while controlling for the impact of cigarette-oriented policies. The net impact of NVPs on smoking prevalence is inferred by comparing the projected No-NVP smoking trends to corresponding trends from two US national surveys. Using the TUS-CPS estimates for the period 2012-2018, we estimate that adult smoking prevalence declined in relative terms by 9.7% (95% CI: 7.5-11.7%) for males and 10.7% (95% CI: 9.1-13.0%) for females. Compared to NHIS, smoking prevalence declined by 10.7% (95% CI: 6.8-14.6%) for males and 11.3% (95% CI: 7.4-15.6%) for females. These impacts were confined mainly to ages 18-44. Vaping-related reductions in smoking prevalence were projected to avert nearly 0.4 million SADs between 2012 and 2052. Our analysis indicates that NVP use is associated with substantial reductions in US smoking prevalence among younger adults.

Citing Articles

Use of nicotine products, prescription drug products, and other methods to stop smoking by US adults in the 2022 National Health Interview Survey.

Foxon F, Niaura R Intern Emerg Med. 2025; .

PMID: 39760947 DOI: 10.1007/s11739-024-03847-6.


Prevention Lab: a predictive model for estimating the impact of prevention interventions in a simulated Italian cohort.

Cianfanelli L, Senore C, Como G, Fagnani F, Catalano C, Tomatis M BMC Public Health. 2024; 24(1):2792.

PMID: 39394566 PMC: 11475107. DOI: 10.1186/s12889-024-20212-6.


Increased e-cigarette use prevalence is associated with decreased smoking prevalence among US adults.

Foxon F, Selya A, Gitchell J, Shiffman S Harm Reduct J. 2024; 21(1):136.

PMID: 39026245 PMC: 11256395. DOI: 10.1186/s12954-024-01056-0.


Measures of youth e-cigarette use: strengths, weaknesses and recommendations.

Selya A, Ruggieri M, Polosa R Front Public Health. 2024; 12:1412406.

PMID: 39015391 PMC: 11250581. DOI: 10.3389/fpubh.2024.1412406.


Evaluating trends in cigarette and HTP use in Japan and measurement issues in the National Health and Nutrition Survey.

Levy D, Issabakhsh M, Warner K, Liber A, Meza R, Cummings M Tob Control. 2024; .

PMID: 38906697 PMC: 11662079. DOI: 10.1136/tc-2023-058526.


References
1.
Rosenberg M, Feuer E, Yu B, Sun J, Henley S, Shanks T . Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Anal. 2012; 32 Suppl 1:S25-38. PMC: 3594098. DOI: 10.1111/j.1539-6924.2011.01662.x. View

2.
Levy D, Rodriguez-Buno R, Hu T, Moran A . The potential effects of tobacco control in China: projections from the China SimSmoke simulation model. BMJ. 2014; 348:g1134. PMC: 3928439. DOI: 10.1136/bmj.g1134. View

3.
Levy D, Cho S, Kim Y, Park S, Suh M, Kam S . SimSmoke model evaluation of the effect of tobacco control policies in Korea: the unknown success story. Am J Public Health. 2010; 100(7):1267-73. PMC: 2882401. DOI: 10.2105/AJPH.2009.166900. View

4.
Zhu S, Zhuang Y, Wong S, Cummins S, Tedeschi G . E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ. 2017; 358:j3262. PMC: 5526046. DOI: 10.1136/bmj.j3262. View

5.
Patel D, Davis K, Cox S, Bradfield B, King B, Shafer P . Reasons for current E-cigarette use among U.S. adults. Prev Med. 2016; 93:14-20. PMC: 5316292. DOI: 10.1016/j.ypmed.2016.09.011. View